EGFR and non-small cell lung carcinoma: After briefly presenting the main current clinical trials concerning the anti-EGFR targeted therapies in early stage NSCLC, this review will deal with the different steps for the setup and management of predictive tests that must be performed in laboratories for the care of these patients.